JPRN-UMIN000025361未知未知
Clinical study about the ocular administration of the anti-VEGF antibody for the retinopathy of prematurity - Clinical study about the retinopathy of prematurity
ara Medical University0 个研究点目标入组 20 人开始时间: 2017年1月10日最近更新:
适应症
试验速览
- 阶段
- 未知
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 50weeks-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Case of Retinal Detachment
研究者
相似试验
招募中
不适用
Clinical evaluation for the effects of intraocular tissue plasminogen activator administration in various eye diseasesVarious eye diseasesJPRN-UMIN000015726Department of Ophthalmology, Shimane University Faculty of Medicine, Izumo, Japan50
招募中
不适用
Investigations of ocular side effects of topically applied 0.002% EYBELISJPRN-UMIN000039592Shohzankai Medical Foundation Miyake Eye Hospital80
已完成
不适用
Ocular surface evaluation in ocular hypertension or inicial glaucoma patients treated with drops.Ocular hypertension or Open angle Glaucoma with no previous treatment.H40.0H40.1RBR-7mmp6kniversidade Federal de São Paulo
已完成
不适用
Clinical study about the intraocular surgery using the adjuvant.The disease should be taken the intraocular surgery such as cataract or retina vitreous disease and others.JPRN-UMIN000029297Fujita Health University28
已完成
不适用
Clinical research about intraocular injection of tissue plasminogen activator(cleactor)diabetes retinopathy,retina vein occlusion,macular degeneration,subretinal hemorrhage,macula edemaJPRN-UMIN000028467Fujita Health University75